Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Backed by Science and Evidence, New Jersey’s Actions Aim to Advance Maternal Health.
- When Doctors Dismiss Symptoms, Patients Suffer Lasting Harm.
- Annual Rutgers Health Faculty Development Symposium – TOMORROW 6/19
- Losing weight in middle age could reduce chronic diseases later, study shows.
- Weill Cornell-Rutgers Health NeuroHIV Research Symposium II on July 8th
Categories
- Community (2,286)
- Covid (987)
- CTO Events (6)
- News (2,911)
- Pilots (21)